(Q37013051)

17 August 2017

1 reference

title

beta-Adrenergic receptor polymorphisms: relationship to the beta-agonist controversy and clinical implications (English)

1 reference

17 August 2017

1

D Robin Taylor

1 reference

PubMed ID

18035963

17 August 2017

language of work or name

English

0 references

publication date

1 December 2007

1 reference

Expert Opinion on Pharmacotherapy

17 August 2017

1 reference

17 August 2017

8

1 reference

17 August 2017

18

1 reference

17 August 2017

3195-3203

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.18.3195

17 August 2017

1 reference

Regular inhaled beta-agonist treatment in bronchial asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.18.3195

Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.18.3195

The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.18.3195

The beta 2-agonist controversy. Observations, explanations and relationship to asthma epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.18.3195

Antithetic regulation by beta-adrenergic receptors of Gq receptor signaling via phospholipase C underlies the airway beta-agonist paradox

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.18.3195

Beta-agonists and asthma: too much of a good thing?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.18.3195

Rapid onset of tolerance to beta-agonist bronchodilation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.18.3195

Adverse effects of short-acting beta-agonists: potential impact when anti-inflammatory therapy is inadequate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.18.3195

Regular beta-adrenergic agonists. Evidence, not reassurance, is what is needed

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.18.3195

Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.18.3195

Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.18.3195

Sequence, haplotype, and association analysis of ADRbeta2 in a multiethnic asthma case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.18.3195

Pharmacology and physiology of human adrenergic receptor polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.18.3195

Systematic review and meta-analysis of the association between {beta}2-adrenoceptor polymorphisms and asthma: a HuGE review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.18.3195

Genetic polymorphisms of the beta 2-adrenergic receptor in nocturnal and nonnocturnal asthma. Evidence that Gly16 correlates with the nocturnal phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.18.3195

Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.18.3195

beta-Adrenergic receptor polymorphisms and response to salmeterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.18.3195

Asthma exacerbations during long term beta agonist use: influence of beta(2) adrenoceptor polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.18.3195

Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.18.3195

Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.18.3195

Arginine-16 beta2 adrenoceptor genotype predisposes to exacerbations in young asthmatics taking regular salmeterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.18.3195

The arginine-16 beta2-adrenoceptor polymorphism predisposes to bronchoprotective subsensitivity in patients treated with formoterol and salmeterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.18.3195

Interactions between corticosteroids and beta2-agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.18.3195

21 January 2018

Severe asthma in adults

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.18.3195

Physiologic and pathologic abnormalities in severe asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.18.3195

Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.18.3195

Heterogeneity of therapeutic responses in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.18.3195

Impact of genetic polymorphisms of the beta2-adrenergic receptor on albuterol bronchodilator pharmacodynamics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.18.3195

Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.18.3195

Bronchodilator response in relation to beta2-adrenoceptor haplotype in patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.18.3195

Comparison of formoterol and terbutaline for as-needed treatment of asthma: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.18.3195

End of New Zealand asthma epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.18.3195

β2-adrenoceptor polymorphisms and asthma from childhood to middle age in the British 1958 birth cohort: a genetic association study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.18.3195

10.1517/14656566.8.18.3195

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference

PubMed ID

18035963